The effects of alfentanil-midazolam anaesthesia upon the electrophysiologic (EP) properties of normal atrioventricular (A-V) and accessory pathway (AP) conduction
Les effets de l' anesthEsie ~ l 'alfentanil-midazolam sur les propriEtEs Electrophysiologiques de la voie de transmission atrioventriculaire norrnale et accessoire sont EtudiEs chez huit porteurs du syndrome de Wolff-Parkinson-White pendant l ' ablation chirurgicale du rEseau accessoire. On avait au prEalable confirmE la presence d'une voie de conduction accessoire par des Etudes Electrophysiologiques prE-opdratoires. L'anesthEsie est induite avec de l'alfentanil (50 Izg 9 kg -j ) et du midazolam (0,15 mg 9 kg -I ) et maintenue avec une perfusion d'alfentanil (2 Izg " kg -t ) et des bolus intermittents de midazolam (1-2 mg q 15 min, PRN). Apr~s la sternotomie, on rEalise une Etude Electrophysiologique de base portant sur la pEriode rEfractaire efficace et la mesure de la longueur du cycle le plus court pendant la conduction antdgrade pour les voies normale et acessoire, ainsi que pendant la conduction rdtrograde pour la voie accessoire. La comparaison avec les dtudes Electrophysiologiques prE-opEratoires montre que l'anesthEsie l'alfentanil-midazolam n'a d'influence ni sur la conduction, ni sur la pEriode rdfractaire efficace de l'une ou l' autre des voies de transmission. Les parambtres hEmo-dynamiques demeurent stables et sans tachyarythmies pendant toute la durEe de l'intervention. Nous en concluons que l'association alfentanilmidazolain est une technique anes-th~sique acceptable pour l' ablation chirurgicale des voies de conduction aberrantes.
Advances in the understanding of the electrophysiology of pathological accessory atrioventricular pathways (AP) in CAN J ANAESTH 1992 / 39:8 / pp 816-21 patients with pre-excitation syndromes, has led to the development of ablative procedures using both surgical and non-surgical techniques. ~-3 Although the recent development of AP ablation using radiofrequency energy has precluded the requirement for surgery in most cases, patients failing this technique may require sternotomy and surgical ablation under general anaesthesia. 4-~ Successful anaesthetic management of these patients includes the suppression of sympathetic stimulation in response to perioperative stimuli while allowing normal physiological expression of the accessory pathway and the normal atrioventricular conduction system to facilitate mapping. 7 ' 8 Various animal models have been used to measure the effects of anaesthetic agents upon conduction in the normal A-V conducting system but an animal model of a pathological accessory pathway does not exist. 9"~~ Inhalational anaesthetics (enflurane, halothane, isoflurane) have been shown to depress conduction in both the normal and AP conducting systems, but no data exist regarding the effects of alfentanil and midazolam upon conduction in animals or humans.~-~3 Therefore, we studied the effect of general anaesthesia, using a combination of alfentanil and midazolam, upon the electrophysiological properties of the normal A-V conduction system and AP, in a group of patients with Wolff-Parkinson-White Syndrome (WPW), undergoing surgical ablation of the accessory pathways.
Methods
With Ethics Committee approval and signed patient consent, eight patients (six men and two women, ASA II) with WPW syndrome were studied. No other concomitant diseases were present. The identification and localization (mapping) of a single or multiple pathological accessory pathway had been confirmed by an electrophysiological (EP) study previously performed using transvenous endocardial electrodes in the EP laboratory. The EP study protocol included: (1) right atrial refractory period determination at cycle lengths of 400 and 500 msec (including right atrial effective refractory (RAERP), AV node effective refractory period (AVNERP), and accessory pathway effective refractory period (APERP)), coupling intervals were in steps of 20 msec from 300 to 400 msec and in steps of 10 msec below 300 msec, (2) right ventricular effective refractory period (RVERP) at a cycle length of 400 msec, (3) shortest cycle length (SCL), also known as the Wenckebach cycle length (WBCL), with 1:1 conduction over the normal AV node (SCL-AVN) and accessory (SCL-AP) pathway. A definition of each of these variables is provided in Table I .
On the day of surgery, patients received pre-medication with lorazepam (0.06 mg. kg -~, sO. Anaesthesia was induced with alfentanil 50 ~g.kg -~, midazolam 0.15 mg-kg -~ iv, and tracheal intubation was facilitated with that tissue. Right atrial effective refractory period -the longest interval between the two impulses that fails to stimulate the atrium (to result in atrial depolarization). Atrioventricular node effective refractory period -the longest coupling interval between two atrial impulses that fails to conduct over the AV node. Accessory pathway effective refractory period -the longest interval between two impulses that fails to conduct through accessory pathway (to result in AP depolarization).
Wenckebach cycle length or shortest cycle length of the atrioventrcular node or accessory pathway, with 1:1 conduction -the shortest interval or the fastest rate at which the AV node/accessory pathway can conduct anterogradely or retrogradely prior to Wenckebach block.
vecuronium 20 mg, iv. Anaesthesia was maintained with a continuous infusion of alfentanil 2 ~g. kg -~ 9 min -~ and intermittent doses of midazolam (1-2 mg, iv) every 15 min, as required. Positive pressure ventilation with airoxygen was used to maintain normocapnia and arterial oxygen saturation greater than 96% (Nellcor Capnograph/ Oximeter). Other monitors included a radial arterial line, central venous pressure (CVP) catheter and a nasopharyngeal temperature probe. After sternotomy, an EP study was performed and recorded using epicardial hexipolar surface electrodes (two stimulating and four recording electrodes) sutured to the right atrium and right ventricle for bipolar pacing and recording.~-~3
For statistical analysis, comparison of the baseline EP study with the EP study performed during alfentanilmidazolam anaesthesia, as well as comparison of haemodynamic variables, arterial blood gas analysis, temperature, PETCO 2, sodium (Na++), potassium (K § calcium (Ca++), and magnesium (Mg++) measured prior to and following induction of anaesthesia, were made using paired Student's t tests. The results are expressed as mean ___ SD. P < 0.05 was considered statistically significant.
Results
The anthropometric characteristics of the eight subjects are shown in Table II . Haemodynamic variables including systolic, diastolic, mean arterial and central venous pressures were similar before and after the induction of alfentanil-midazolam anaesthesia (Table III) , although there was a tendency for arterial blood pressure to decrease Mean -+SD with induction of anaesthesia. EP studies began approximately 20--30 min postinduction and there was no change in heart rate or arterial blood pressure in response to surgical stimuli during this period. Arterial blood gas analysis, temperature, PETCO 2, K § Na § Ca ++, and Mg ++ were within normal limits, and did not change with induction of anaesthesia (Table IV) . PETCO 2 and oxygen saturation (pulse oximetry) remained constant throughout the procedure.
Comparison of EP studies performed preoperatively and following induction of alfentanil-midazolam anaesthesia showed no detectable difference in conduction or refractory periods in the normal A-V conduction system during anterograde conduction, or in the accessory pathway during antegrade and retrograde conduction (Table V) . Accordingly, since our data suggests the possibility of alfentanil-midazolam as having no effect, we examined our results post-hoc for the probability of a type II error. Specifically, we tested for the probability of failure to detect a 20% difference using the power of a test of significance equation ~4 since changes of this magnitude are not clinically important. The calculated beta value was <0.06. Therefore, we conclude a difference in conduction variables I> 20% was not present during alfentanil-midazolam administration.
All accessory pathways were successfully identified and surgically ablated. As well, no tachyarrhythmias occurred during general anaesthesia other than those induced during the EP study.
Discussion
The criteria for an optimal anaesthetic administered for ablative procedures for pathological accessory pathways include: (i) minimal effect by anaesthetic agents on conduction in either the normal A-V conduction system or in the accessory pathway(s) and (ii) adequate suppression of the sympathetic response to induction, intubation and surgical stimulation. Our results show that a combination of alfentanil and midazolam had no effect upon conduction in either the normal A-V conduction system or in the accessory pathways and, as well, adequately suppressed any haemodynamic response to surgery.
The WPW syndrome is the most common pre-excitation syndrome and is characterized by an accessory pathway between the atrium and ventricle located in the A-V sulcus. This anomalous bypass tract shares characteristics of normal myocardial fibres and is capable of transmitting impulses in both an antegrade and retrograde direction, at very high rates) s The most common tachyarrhythmias associated with WPW are atrioventricular reentrant or atrial fibrillation, or both, with a fast ventricular response due to rapid conduction over the AP tract. Therefore, any perioperative stress resulting in sympathetic stimulation may potentially precipitate atrial fibrillation or supraventricular tachycardia resulting in a rapid ventricular response.
The absence of effect of alfentanil-midazolam on the electrophysiological properties of normal and AP conducting tissue is an important characteristic for any anaesthetic agent that would be utilized during ablative procedures. For example, we have shown that the inhalational agents halothane, isoflurane and enflurane depress conduction in both the normal A-V conduction system and accessory pathway. ~-~3 Therefore, the use of these agents or any agent that is capable of depressing conduction in either pathway may make identification of the accessory pathway difficult and jeopardize the ablation procedure.
It is also important not to alter the electrophysiological milieu. Electrical transmission over the AP depends on sodium-dependent fast-inward current, whereas the AV node utilizes a calcium-dependent slow-inward current. Any changes in plasma concentration of these ions, as well as K § and Mg §247 and thus transmembrane gradients, or changes in ion concentration due to pH changes, may have considerable impact upon transmission in either pathway. 7' m6 As anticipated, there were no changes in these variables following induction of anaesthesia (Table IV) .
Our study also demonstrated that a 50 p.g-kg -~ bolus of alfentanil followed by an infusion of 2 jxg-kg -~. min -~ with the concomitant administration of midazolam pro, vided a very stable and sufficient level of anaesthesia throughout the ablative procedure in all patients. It is desirable that the depth of anaesthesia is adequate to suppress any sympathetic response to surgical stimulation to prevent the induction of tachyarrhythmias. In our study, there were no unprovoked incidences of tachyarrhythmia prior to ablation of the accessory pathway. However, there was a tendency for arterial blood pressure to decrease following anaesthetic inducuon with alfentanil, which would likely attain statistical significance with a larger sample size. Alfentanil shares many of the cardiovascular properties of fentanyl and sufentanil; however, it has been shown to have a greater tendency to produce hypotension, and consequently a higher incidence of ischaemia, in patients with coronary artery disease. ~7 Furthermore, DeLange et al. concluded that alfentanil was less reliable than sufentanil or fentanyl for blocking the sympathetic response to induction, sternotomy, sternal spread or aortotomy in patients undergoing coronary artery bypass grafting.~S However, the dosage of alfentanil we employed resulted in a very stable haemodynamic state with minimal sympathetic response to surgical stimuli. In addition, the patient population presenting for ablative procedures is relatively young (Table I) , and therefore the presence of coronary artery disease is unlikely. As such, the potential for hypotension to induce myocardial ischaemia in this population is much less of a concern.
The recent development and success of transcatheter ablation via the transvenous route has diminished the need for sternotomy under general anaesthesia to permit surgical ablation. Nonetheless, operative ablation is still necessary in patients who have failed transcatheter ablation due to accessory pathways in anatomical locations difficult to reach.
In our practice this occurs in 5-10% of cases, consistent with experiences reported elsewhere. 5't9'2~ It is in this group of. patients who present for surgical ablation that knowledge of the effect of anaesthetic agents upon conduction through the normal A-V and AP becomes particularly important. Any substantial effect upon conduction in either pathway, such as with the inhalational anaesthetics, will make the EP mapping more difficult in what is an already challenging case. Other patient populations who may require general anaesthesia for transcatheter ablation are young paediatric patients and adult patients who are agitated. In our experience, most patients are successfully ablated under neuroleptanaesthesia using a combination of midazolam (1-3 mg q15 rain, PRN) and alfentanil (500-1000 I.Lg q15-30 min, PRN). Patient compliance and comfort is much improved with this technique and, at the doses employed, we anticipate no electrophysiological effects of these drugs.
Where general anaesthesia for sternotomy and subsequent surgical ablation is required, midazolam and alfentanil are again our agents of choice. Inhalational anaesthesia should be avoided because of the previously demonstrated depressive effects on both the normal A-V conducting system and accessory pathway. "-~3 The effect of fentanyl on conduction is controversial. G6mez-Arnau et al. found that fentanyl had no effect on accessory pathway conduction in patients with WPW. 2~ However, a previous study in dogs of the effects of fentanyl on conduction in the normal A-V conduction, system demonstrated prolongation of AV node conduction, AV node effective and functional refractory periods, and ventricular effective refractory periods, using both low (100 Ixg" kg -~) and high dose (400 i~g.kg -~) regimens. 22 Therefore, fentanyl may make induction of atfioventricular reentrant tachycardia difficult and complicate mapping. At present, no data exists regarding the electrophysiological effects of morphine on conduction in AP.
Sufentanil would be an appropriate agent to administer to patients undergoing sternotomy for surgical ablative procedures since we have previously shown it has minimal affecton conduction in either the normal A-V conduction system or accessory pathway. 23 However, alfentanil is a more suitable agent because of its rapid onset and shorter elimination half-life, and therefore, less likely to cause respiratory depression requiring postoperative ventilation. Because of its lipid solubility and volume of distribution, less alfentanil is stored in the brain which explains alfentanil's rapid decline in activity after cessation of drug infusion. 24 Following an intravenous bolus dose of alfentanil 50 p,g. kg -~, as used in our study, plasma therapeutic levels (>400 ng. ml -t) will be achieved. 25 However, unless a constant infusion is initiated following the administration of a bolus dose, then plasma concentrations will decrease to below 300 ng .ml -~ within three to five minutes. 26 As the total amount of alfentanil administered is increased, its termination of action will become more dependent upon elimination rather than redistribution. From our experience, we terminated the infusion approximately 20 min before the end of the procedure, which resulted in the patients breathing spontaneously and waking appropriately. No patients required postoperative ventilation or naloxone administration. Under usual circumstances, spontaneous ventilation will occur with serum levels of alfentanil less than 200 ng. ml-~. 27 In conclusion, our study demonstrates that the administration of alfentanil and midazolam has no effect upon conduction in either the normal A-V conduction system or accessory pathways in patients with WPW. Furthermore, this combination proved to be a very reliable and haemodynamically stable anaesthetic. It is very suitable for anaesthesia in patients undergoing ablative procedures for accessory pathways.
